VRS
ARCT icon

Virginia Retirement Systems’s Arcturus Therapeutics ARCT Stock Holding History

Virginia Retirement Systems’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-21,354
Closed -$226K – 938
2025
Q1 		$226K Buy
+21,354
New +$339K ﹤0.01% 935
2023
Q3 		$258K Sell
10,100
-1,100
-10% -$33.9K ﹤0.01% 834
2023
Q2 		$321K Buy
+11,200
New +$305K ﹤0.01% 824
2020
Q4 		– Sell
-7,200
Closed -$309K – 1105
2020
Q3 		$309K Buy
+7,200
New +$357K ﹤0.01% 923

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Virginia Retirement Systems's ARCT Position: Q2 2025 in Review

Virginia Retirement Systems sold out of Arcturus Therapeutics (ARCT) in Q2 2025, closing a stake of 21,354 shares — an estimated $226K sold.

Virginia Retirement Systems first reported a position in ARCT in Q3 2020 and held it in 4 quarters. The position peaked at $321K in Q2 2023. 143 funds tracked by Wall St. Rank hold ARCT as of Q2 2025.

  • Virginia Retirement Systems reported no remaining Arcturus Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Virginia Retirement Systems sold 21,354 Arcturus Therapeutics shares in Q2 2025, an estimated $226K.
  • Virginia Retirement Systems first reported a position in Arcturus Therapeutics in Q3 2020 and held it in 4 quarters.
  • Virginia Retirement Systems's Arcturus Therapeutics position peaked at $321K in Q2 2023.
  • 143 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2025.

Based on Virginia Retirement Systems's 13F filing for Q2 2025, filed 29 Jul 2025.